| Jan'20 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Net sales | ||||||||||
150,185 | 123,954 | 90,611 | 82,432 | 77,123 | 74,987 | 72,215 | 63,783 | 62,765 | 54,958 | 51,060 |
Cost of sales | ||||||||||
38,231 | 32,444 | 26,331 | 24,063 | 24,400 | 26,164 | 21,906 | 19,492 | 20,396 | 19,882 | 19,737 |
Gross profit | ||||||||||
111,954 | 91,510 | 64,280 | 58,369 | 52,723 | 48,823 | 50,309 | 44,291 | 42,369 | 35,076 | 31,323 |
Selling, general and administrative expenses: | ||||||||||
General and administrative | ||||||||||
29,313 | 24,287 | 19,465 | 21,671 | 19,604 | 18,287 | 16,771 | 15,150 | 14,932 | 14,778 | 15,009 |
Marketing and selling | ||||||||||
45,491 | 38,600 | 28,402 | 28,685 | 23,695 | 25,879 | 23,888 | 21,281 | 17,726 | 17,176 | 15,300 |
Research and development | ||||||||||
25,298 | 22,028 | 20,044 | 20,668 | 14,761 | 12,363 | 6,708 | 6,444 | 5,868 | 5,724 | 5,893 |
Medical device tax | ||||||||||
- | - | - | - | - | - | - | 0 | 0 | - | - |
Other general and administrative expenses | ||||||||||
- | - | - | - | - | 321 | 2,242 | 2,636 | 1,060 | 0 | - |
Total selling, general and administrative expenses | ||||||||||
100,102 | 84,915 | 67,911 | 71,024 | - | - | - | - | - | - | - |
Operating income (loss) | ||||||||||
11,852 | 6,595 | -3,631 | -12,655 | -5,337 | -8,027 | 700 | -1,220 | 2,783 | -2,602 | -4,879 |
Other income (expense), net: | ||||||||||
Interest income, net | ||||||||||
988 | 165 | -112 | -112 | 78 | 154 | 170 | 291 | 523 | 896 | 1,317 |
Interest income | ||||||||||
- | - | - | - | - | 51 | 59 | 59 | 32 | 43 | 67 |
Loss on foreign currency transactions | ||||||||||
-517 | -836 | 819 | -147 | -949 | -896 | 39 | 111 | 86 | -87 | 124 |
Royalty income | ||||||||||
551 | 633 | 581 | 618 | 740 | 355 | 422 | - | - | - | - |
Other income, net | ||||||||||
152 | 82 | 47 | -148 | 19 | 26 | 64 | 822 | 326 | 128 | 257 |
Loss on early extinguishment of note payable | ||||||||||
- | - | - | - | - | - | - | - | - | -267 | - |
Total other income (expense), net | ||||||||||
1,174 | 44 | 1,335 | 211 | -268 | -618 | 414 | 701 | -79 | -1,079 | -869 |
Income (loss) before income taxes | ||||||||||
13,026 | 6,639 | -2,296 | -12,444 | -5,605 | -8,645 | 1,114 | -519 | 2,704 | -3,681 | -5,748 |
Provision (benefit) for income taxes | ||||||||||
-1,022 | 1,671 | -157 | -315 | 928 | -253 | 716 | 1,244 | 1,356 | 432 | 1,154 |
Income (loss) from continuing operations | ||||||||||
- | - | - | - | - | - | - | - | - | -4,113 | -6,902 |
Income from discontinued operations, net of income taxes | ||||||||||
- | - | - | - | - | - | - | - | - | 4,166 | 702 |
Net income (loss) | ||||||||||
14,048 | 4,968 | -2,139 | -12,129 | -6,533 | -8,392 | 398 | -1,763 | 1,348 | 53 | -6,200 |
Net income (loss) per share: | ||||||||||
Net loss per share - basic and diluted | ||||||||||
- | - | - | - | -0.17 | -0.22 | - | - | - | - | - |
Weighted average shares outstanding - basic and diluted | ||||||||||
- | - | - | - | 39,260 | 38,091 | - | - | - | - | - |
Income (loss) per share from continuing operations - basic (in dollors per share) | ||||||||||
- | - | - | - | - | - | - | - | - | -0.12 | -0.21 |
Income (loss) per share from continuing operations - diluted (in dollors per share) | ||||||||||
- | - | - | - | - | - | - | - | - | -0.12 | -0.21 |
Income per share from discontinued operations - basic and diluted (in dollors per share) | ||||||||||
- | - | - | - | - | - | - | - | - | 0.12 | 0.02 |
Basic | ||||||||||
0.32 | 0.12 | -0.05 | -0.30 | - | - | 0.01 | -0.05 | 0.04 | 0.00 | -0.19 |
Diluted | ||||||||||
0.30 | 0.11 | -0.05 | -0.30 | - | - | 0.01 | -0.05 | 0.04 | 0.00 | -0.19 |
Weighted average shares outstanding: | ||||||||||
Basic | ||||||||||
44,493 | 42,587 | 41,004 | 40,329 | - | - | 36,706 | 36,253 | 35,434 | 34 | 32,498 |
Diluted | ||||||||||
46,895 | 45,257 | 41,004 | 40,329 | - | - | 38,607 | 36,253 | 36,878 | 34 | 32,498 |